The HIV Prevention Trials Network 052 (HPTN 052) study, led by Myron S. Cohen, MD, FIDSA, of the University of North Carolina (UNC) in Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science. HPTN 052 evaluated whether antiretroviral drugs can prevent sexual transmission of HIV among couples in which one partner has HIV and the other does not. The research found that early treatment with antiretroviral therapy reduced sexual transmission of HIV in these couples by at least 96 percent. Time magazine also highlighted HIV treatment as prevention as one of the top 10 medical breakthroughs of 2011.
Dr. Cohen is associate vice chancellor for global health and the J. Herbert Bate Distinguished Professor of Medicine, Microbiology, and Immunology at UNC; public health director for the UNC Institute of Global Health; and infectious disease chief in the Division of Clinical Infectious Diseases. A member of HIVMA and the Center for Global Health Policy’s Scientific Advisory Committee, Dr. Cohen has also served on the IDSA Annual Meeting Program Committee.
< Previous Article | Next Article >